Key result
Perinatal stroke has a multifactorial etiology with limited treatment options; anticoagulation is rarely indicated for arterial ischemic stroke but appears safe for cerebral sinovenous thrombosis.
Why the study?
What are the epidemiology, risk factors, and treatment strategies for perinatal arterial ischemic stroke and cerebral sinovenous thrombosis?
Population
Neonates and mothers at risk for or experiencing perinatal arterial ischemic stroke and cerebral sinovenous…
Design
Review
Authors
Loading...
Anticoagulation may be considered for perinatal CSVT but not AIS; leaves open need for RCTs to confirm safety and efficacy.
What are the epidemiology, risk factors, and treatment strategies for perinatal arterial ischemic stroke and cerebral sinovenous thrombosis?
This review highlights that while anticoagulation is rarely indicated for perinatal arterial ischemic stroke, it appears safe and potentially effective for cerebral sinovenous thrombosis, though further clinical trials are needed.
Sarah H. O’Brien (2015) conducted a review in Perinatal arterial ischemic stroke (PAIS) and cerebral sinovenous thrombosis (CSVT). Perinatal stroke has a multifactorial etiology with limited treatment options; anticoagulation is rarely indicated for arterial ischemic stroke but appears safe for cerebral sinovenous thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: